In Vitro Bactericidal Activity of Trimethoprim-Sulfamethoxazole/Colistin Combination Against Carbapenem-Resistant Klebsiella pneumoniae Clinical Isolates

被引：12
|
作者：
Su, Jiachun [1 ,2 ]
Li, Dan [1 ,2 ]
Guo, Qinglan [1 ,2 ]
Guo, Yan [1 ,2 ]
Zheng, Yonggui [1 ,2 ]
Xu, Xiaogang [1 ,2 ,3 ]
机构：
[1] Fudan Univ, Huashan Hosp, Inst Antibiot, 12 Middle Wulumuqi Rd, Shanghai 200040, Peoples R China
[2] Natl Hlth & Family Planning Commiss, Key Lab Clin Pharmacol Antibiot, Shanghai, Peoples R China
[3] Fudan Univ, Huashan Hosp, Natl Clin Res Ctr Aging & Med, Shanghai, Peoples R China
来源：
MICROBIAL DRUG RESISTANCE | 2019年 / 25卷 / 02期
关键词：
carbapenem-resistant Klebsiella pneumoniae; trimethoprim-sulfamethoxazole; colistin; bactericidal activity; COLISTIN; THERAPY;
D O I：
10.1089/mdr.2018.0085
中图分类号：
R51 [传染病];
学科分类号：
100401 ;
摘要：
Carbapenem-resistant Klebsiella pneumoniae (CRKP) has emerged as a formidable health challenge in recent years owing to the shortage of effective antibiotics. Colistin is the last and sometimes the only therapeutic option for CRKP infections. Unfortunately, resistance to colistin monotherapy is likely to develop. CRKP in China reportedly exhibit low rates of resistance to trimethoprim-sulfamethoxazole. The aim of this study was to evaluate the in vitro efficacy of trimethoprim-sulfamethoxazole in combination with colistin against four CRKP clinical isolates. The trimethoprim-sulfamethoxazole/colistin combination rapidly killed all four of the tested isolates after 2 h up to 24 h. Trimethoprim-sulfamethoxazole is one of the few remaining antimicrobials with some activity against CRKP. In particular, combined with colistin, trimethoprim-sulfamethoxazole might be promising for the treatment of CRKP infections.
引用
收藏
页码：152 / 156
页数：5
相关论文
共 50 条
  • [31] IN VITRO ACTIVITY OF COLISTIN OR SULBACTAM IN COMBINATION WITH FOSFOMYCIN OR IMIPENEM AGAINST CLINICAL ISOLATES OF CARBAPENEM-RESISTANT ACINETOBACTER BAUMANNII PRODUCING OXA-23 CARBAPENEMASES
    Santimaleeworagun, Wichai
    Wongpoowarak, Payom
    Chayakul, Pantip
    Pattharachayakul, Sutthiporn
    Tansakul, Pimpimon
    Garey, Kevin W.
    SOUTHEAST ASIAN JOURNAL OF TROPICAL MEDICINE AND PUBLIC HEALTH, 2011, 42 (04) : 890 - 900
  • [32] Multicenter Study of Colistin Heteroresistance in Carbapenem-Resistant Klebsiella pneumoniae Strains in China
    Weng, Yuesong
    Wang, Tao
    Huang, Bin
    Yu, Hua
    Jia, Wei
    Shan, Bin
    Qu, Fen
    Tang, Yiwei
    Chen, Liang
    Du, Hong
    MICROBIOLOGY SPECTRUM, 2023, 11 (04):
  • [33] Dose-Dependent Synergistic Interactions of Colistin with Rifampin, Meropenem, and Tigecycline against Carbapenem-Resistant Klebsiella pneumoniae Biofilms
    Geladari, Anastasia
    Simitsopoulou, Maria
    Antachopoulos, Charalampos
    Roilides, Emmanuel
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2019, 63 (03)
  • [34] In vitro activity of cefiderocol, a siderophore cephalosporin, against carbapenem-resistant hypervirulent Klebsiella pneumoniae in China
    Zhao, Jiankang
    Pu, Danni
    Li, Ziyao
    Liu, Xinmeng
    Zhang, Yulin
    Wu, Yongli
    Zhang, Feilong
    Li, Chen
    Zhuo, Xianxia
    Lu, Binghuai
    Cao, Bin
    ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 2023,
  • [35] In Vitro Activities of Tigecycline in Combination with Amikacin or Colistin Against Carbapenem-Resistant Acinetobacter baumannii
    Wu, Hongbin
    Feng, Heqiang
    He, Lijie
    Zhang, Heping
    Xu, Ping
    APPLIED BIOCHEMISTRY AND BIOTECHNOLOGY, 2021, 193 (12) : 3867 - 3876
  • [36] In Vitro Activities of Tigecycline in Combination with Amikacin or Colistin Against Carbapenem-Resistant Acinetobacter baumannii
    Hongbin Wu
    Heqiang Feng
    Lijie He
    Heping Zhang
    Ping Xu
    Applied Biochemistry and Biotechnology, 2021, 193 : 3867 - 3876
  • [37] In Vitro Synergistic Activity of Antimicrobial Combinations against Carbapenem- and Colistin-Resistant Acinetobacter baumannii and Klebsiella pneumoniae
    Mantzana, Paraskevi
    Protonotariou, Efthymia
    Kassomenaki, Angeliki
    Meletis, Georgios
    Tychala, Areti
    Keskilidou, Eirini
    Arhonti, Maria
    Katsanou, Charikleia
    Daviti, Aikaterini
    Vasilaki, Olga
    Kagkalou, Georgia
    Skoura, Lemonia
    ANTIBIOTICS-BASEL, 2023, 12 (01):
  • [38] Risk Factors for the Development of Colistin Resistance during Colistin Treatment of Carbapenem-Resistant Klebsiella pneumoniae Infections
    Huang, Po-Han
    Chen, Wen-Yin
    Chou, Sheng-Hua
    Wang, Fu-Der
    Lin, Yi-Tsung
    MICROBIOLOGY SPECTRUM, 2022, 10 (03):
  • [39] Synergistic activity of fosfomycin-meropenem and fosfomycin-colistin against carbapenem resistant Klebsiella pneumoniae: an in vitro evidence
    Bakthavatchalam, Yamuna Devi
    Shankar, Abirami
    Sethuvel, Dhiviya Prabaa Muthuirulandi
    Asokan, Kalaiarasi
    Kanthan, Kalaiarasi
    Veeraraghavan, Balaji
    FUTURE SCIENCE OA, 2020, 6 (04):
  • [40] In Vitro Activity of Eravacycline in Combination with Colistin Against OXA-type Carbapenemase Producing Klebsiella pneumoniae Isolates
    Ozger, H. Selcuk
    Cuhadar, Tugba
    Yildiz, Serap Suzuk
    Gulmez, Zehra Demirbas
    Tunccan, Ozlem Guzel
    Kalkanci, Ayse
    Simsek, Husniye
    Bakkaloglu, Zekiye
    Dizbay, Murat
    GAZI MEDICAL JOURNAL, 2021, 32 (2A): : 276 - 280
12345